452 related articles for article (PubMed ID: 29425808)
1. Metabolism of 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D
Yasuda K; Tohyama E; Takano M; Kittaka A; Ohta M; Ikushiro S; Sakaki T
J Steroid Biochem Mol Biol; 2018 Apr; 178():333-339. PubMed ID: 29425808
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of the CYP24A1 major metabolite of 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D
Takano M; Yasuda K; Tohyama E; Higuchi E; Sakaki T; Kittaka A
J Steroid Biochem Mol Biol; 2017 Oct; 173():75-78. PubMed ID: 27923594
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, metabolism, and biological activity of 2-[3-(tetrazolyl)propyl]-1α,25-dihydroxy-19-norvitamin D
Takano M; Yasuda K; Higuchi E; Tohyama E; Takeuchi A; Sakaki T; Kittaka A
J Steroid Biochem Mol Biol; 2016 Nov; 164():40-44. PubMed ID: 26232635
[TBL] [Abstract][Full Text] [Related]
4. Human cytochrome P450-dependent differential metabolism among three 2α-substituted-1α,25-dihydroxyvitamin D(3) analogs.
Yasuda K; Ikushiro S; Kamakura M; Takano M; Saito N; Kittaka A; Chen TC; Ohta M; Sakaki T
J Steroid Biochem Mol Biol; 2013 Jan; 133():84-92. PubMed ID: 22982757
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and metabolic studies of 1α,2α,25-, 1α,4α,25- and 1α,4β,25-trihydroxyvitamin D3.
Takano M; Sawada D; Yasuda K; Nishikawa M; Takeuchi A; Takagi K; Horie K; Reddy GS; Chen TC; Sakaki T; Kittaka A
J Steroid Biochem Mol Biol; 2015 Apr; 148():34-7. PubMed ID: 25263656
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of 1α,2α,25-trihydroxyvitamin D3: active metabolite of 2α-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 by human CYP3A4.
Takano M; Ohya S; Yasuda K; Nishikawa M; Takeuchi A; Sawada D; Sakaki T; Kittaka A
Chem Pharm Bull (Tokyo); 2014; 62(2):182-4. PubMed ID: 24492588
[TBL] [Abstract][Full Text] [Related]
7. Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1.
Rhieu SY; Annalora AJ; LaPorta E; Welsh J; Itoh T; Yamamoto K; Sakaki T; Chen TC; Uskokovic MR; Reddy GS
J Cell Biochem; 2014 Aug; 115(8):1392-402. PubMed ID: 24535953
[TBL] [Abstract][Full Text] [Related]
8. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
Kaufmann M; Lee SM; Pike JW; Jones G
Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of vitamin D3 by cytochromes P450.
Sakaki T; Kagawa N; Yamamoto K; Inouye K
Front Biosci; 2005 Jan; 10():119-34. PubMed ID: 15574355
[TBL] [Abstract][Full Text] [Related]
10. Metabolic stability of 3-epi-1α,25-dihydroxyvitamin D3 over 1 α 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1.
Rhieu SY; Annalora AJ; Wang G; Flarakos CC; Gathungu RM; Vouros P; Sigüeiro R; Mouriño A; Schuster I; Palmore GT; Reddy GS
J Cell Biochem; 2013 Oct; 114(10):2293-305. PubMed ID: 23606409
[TBL] [Abstract][Full Text] [Related]
11. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D Analogs with Nitrogen Atom at C2 Substitution and Effect on Bone Formation.
Kittaka A; Takano M; Saitoh H
Vitam Horm; 2016; 100():379-94. PubMed ID: 26827960
[TBL] [Abstract][Full Text] [Related]
13. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
14. Selection of High-Quality Spermatozoa May Be Promoted by Activated Vitamin D in the Woman.
Bøllehuus Hansen L; Rehfeld A; de Neergaard R; Nielsen JE; Iversen LH; Boisen IM; Mortensen LJ; Lanske B; Almstrup K; Carlsen E; Berg AH; Jørgensen N; Andersen AN; Juul A; Blomberg Jensen M
J Clin Endocrinol Metab; 2017 Mar; 102(3):950-961. PubMed ID: 27977320
[TBL] [Abstract][Full Text] [Related]
15. 1α,25-Dihydroxyvitamin D
Ishizawa M; Akagi D; Yamamoto J; Makishima M
J Steroid Biochem Mol Biol; 2017 Sep; 172():55-61. PubMed ID: 28578001
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.
Ono Y
J Steroid Biochem Mol Biol; 2014 Jan; 139():88-97. PubMed ID: 24139874
[TBL] [Abstract][Full Text] [Related]
17. 24R,25-dihydroxyvitamin D3 promotes the osteoblastic differentiation of human mesenchymal stem cells.
Curtis KM; Aenlle KK; Roos BA; Howard GA
Mol Endocrinol; 2014 May; 28(5):644-58. PubMed ID: 24597546
[TBL] [Abstract][Full Text] [Related]
18. The vitamin D receptor in the proximal renal tubule is a key regulator of serum 1α,25-dihydroxyvitamin D₃.
Wang Y; Zhu J; DeLuca HF
Am J Physiol Endocrinol Metab; 2015 Feb; 308(3):E201-5. PubMed ID: 25425001
[TBL] [Abstract][Full Text] [Related]
19. Robust osteogenic efficacy of 2α-heteroarylalkyl vitamin D analogue AH-1 in VDR (R270L) hereditary vitamin D-dependent rickets model rats.
Nishikawa M; Murose N; Mano H; Yasuda K; Isogai Y; Kittaka A; Takano M; Ikushiro S; Sakaki T
Sci Rep; 2022 Jul; 12(1):12517. PubMed ID: 35869242
[TBL] [Abstract][Full Text] [Related]
20. Isolation, identification and biological activity of 24R,25-dihydroxy-3-epi-vitamin D3: a novel metabolite of 24R,25-dihydroxyvitamin D3 produced in rat osteosarcoma cells (UMR 106).
Kamao M; Tatematsu S; Reddy GS; Hatakeyama S; Sugiura M; Ohashi N; Kubodera N; Okano T
J Nutr Sci Vitaminol (Tokyo); 2001 Apr; 47(2):108-15. PubMed ID: 11508700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
